Clinical and Forensic Toxicology News: June 2021

An AACC/CAP Educational Newsletter for Toxicology Laboratories
CFTN is registered with the U.S. Library of Congress, ISSN 2374-9679

Read the June 2021 issue of CFTN

U.S. Military Forensic Drug Testing (page 1)

The U.S. Department of Defense Military Personnel Drug Abuse Testing Program lays out the guidelines for the military’s sweeping, well-established forensic drug testing program. The purpose of the program is to deter service members from abusing both illegal and prescription drugs, and test results are used for punitive and non-punitive actions to include discharge from military service.

CBD Use in the U.S. Pain Management Population (page 7)

Cannabinoids have gained interest in recent years as an alternate chronic pain treatment option. The use of cannabinoids, the active components of the cannabis plant, for help in treating pain has been a long-standing controversy, but recent changing political and societal viewpoints surrounding cannabis use in the US and around the world has brought increased interest to using cannabis for medical purposes, including treatment of pain.

A Short Review of Naloxone (page 10)

Naloxone is an important tool as an antidote during the epidemic of opioid overdose. The FDA requires that naloxone be included in all labeling of opioid pain medicine and medicine to treat opioid use disorders and recommends that all healthcare professionals discuss the availability of naloxone with patients and caregivers, both when beginning and renewing treatment.

Contact the editors with any comments or questions.